TP53-mutation status by gene-expression signature (TP53 signature) and prediction of efficacy of neoadjuvant chemotherapy (NAC) and recurrence after surgery in breast cancer.

11069 Background: TP53 mutation is an independent poor prognostic factor in breast cancer. We have reported that status of the TP53 mutation is predictable by expression profile of 33 genes (‘TP53 ...